NETHERTON NOW
Live / Allowed — Notice of allowance issued (as of 18 Nov 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 13 Nov 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98850671
- Mark type
- Stylized text
- Filed
- 13 Nov 2024
- Published for opposition
- 23 Sept 2025
- Attorney of record
- Megan E. Spitz
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical product and therapeutic pharmaceutical product for Netherton Syndrome, and rare and orphan skin diseases
- Class 042 — Scientific and technological services: Pharmaceutical development of therapeutic pharmaceuticals for the treatment of diseases
Owner
- Quoin Pharmaceuticals, Inc., Ashburn, VA, US
- Quoin Pharmaceuticals, Inc., Ashburn, VA, US
Prosecution history
- 18 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Sept 2025 — PUBLISHED FOR OPPOSITION
- 17 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Aug 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Aug 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 13 Aug 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 15 May 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 15 May 2025 — NON-FINAL ACTION E-MAILED
- 15 May 2025 — NON-FINAL ACTION WRITTEN
- 08 May 2025 — ASSIGNED TO EXAMINER
- 26 Apr 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 13 Nov 2024 — NEW APPLICATION ENTERED